No specific molecular drug target

The term No specific molecular drug target refers to a classification for therapeutic agents that exert their effects through non-specific physical or chemical mechanisms rather than by binding to a specific biological macromolecule such as a receptor, enzyme, or ion channel (DrugBank, 2024). This category includes agents like antacids, which neutralize gastric acid through a direct chemical reaction, and osmotic diuretics or laxatives, which create physical pressure gradients to move water (StatPearls, 2023). For instance, magnesium hydroxide reacts directly with hydrochloric acid in the stomach to reduce acidity, while polyethylene glycol works by retaining water in the intestinal lumen through osmotic forces (NIH, 2023). Additionally, it encompasses chelating agents that bind metal ions in the bloodstream and adsorbents like activated charcoal that physically trap toxins to prevent their absorption (PubMed, 2022). While these agents are clinically effective, they do not follow the traditional lock and key model of pharmacology. Consequently, their pharmacodynamics are often governed by concentration and physical properties rather than affinity for a specific protein site (ChEMBL, 2024).

Other names

Non-specific targetUnknown targetUnspecified targetNon-macromolecular mechanismPhysical/Chemical action

Drugs in this category operate through physical or chemical processes rather than binding to a specific protein or nucleic acid. Examples include chemical neutralization of acids, creation of osmotic gradients, physical adsorption of toxins, or chemical chelation of metal ions.